Cargando…
Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation
SARS-CoV-2 causes the severe respiratory disease COVID-19. Remdesivir (RDV) was the first fast-tracked FDA approved treatment drug for COVID-19. RDV acts as an antiviral ribonucleoside (adenosine) analogue that becomes active once it accumulates intracellularly. It then diffuses into the host cell a...
Autores principales: | DeFoor, Nicole, Paul, Swagatika, Li, Shuang, Basso, Erwin K. Gudenschwager, Stevenson, Valentina, Browning, Jack L., Prater, Anna K., Brindley, Samantha, Tao, Ge, Pickrell, Alicia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504289/ https://www.ncbi.nlm.nih.gov/pubmed/37714940 http://dx.doi.org/10.1038/s41598-023-42704-y |
Ejemplares similares
-
Modulation of mtDNA copy number ameliorates the pathological consequences of a heteroplasmic mtDNA mutation in the mouse
por: Filograna, R., et al.
Publicado: (2019) -
p53 regulates mtDNA copy number and mitocheckpoint pathway
por: Kulawiec, Mariola, et al.
Publicado: (2009) -
Nuclear genetic control of mtDNA copy number and heteroplasmy in humans
por: Gupta, Rahul, et al.
Publicado: (2023) -
ALS spinal neurons show varied and reduced mtDNA gene copy numbers and increased mtDNA gene deletions
por: Keeney, Paula M, et al.
Publicado: (2010) -
Nuclear genetic control of mtDNA copy number and heteroplasmy in humans
por: Gupta, Rahul, et al.
Publicado: (2023)